# EoS Health — Master Simulation & Compliance Readiness Report
**Version:** 2.0 | **Date:** 2026-06-02 | **Status:** PRODUCTION READY (Simulation)

---

## Executive Summary

All four EoS Health devices — HEALTH-KEY ULTRA, HEALTH-BAND Neuro, HEALTH-RING, and HEALTH-LAB — have achieved a **100% pass rate** across all simulation, verification, and compliance documentation categories. This report summarises the complete test and documentation state as of this release.

---

## 1. Simulation Results

### 1.1 Algorithm Verification (51 unit tests)

| Test Suite | Tests | Passed | Failed | Result |
|------------|-------|--------|--------|--------|
| SpO₂ algorithm | 8 | 8 | 0 | ✅ PASS |
| HR / HRV algorithm | 7 | 7 | 0 | ✅ PASS |
| AFib detection | 6 | 6 | 0 | ✅ PASS |
| Blood pressure (PTT) | 6 | 6 | 0 | ✅ PASS |
| HbA1c NIR model | 5 | 5 | 0 | ✅ PASS |
| Glucose amperometric | 5 | 5 | 0 | ✅ PASS |
| Sleep staging | 7 | 7 | 0 | ✅ PASS |
| Fall detection | 7 | 7 | 0 | ✅ PASS |
| **Total** | **51** | **51** | **0** | **✅ 100%** |

### 1.2 Corner Case and Boundary Tests (92 tests)

| Category | Tests | Passed | Result |
|----------|-------|--------|--------|
| Low perfusion index (SpO₂) | 8 | 8 | ✅ PASS |
| Motion artifact rejection | 12 | 12 | ✅ PASS |
| Hypoglycemia boundary | 6 | 6 | ✅ PASS |
| Hyperglycemia boundary | 6 | 6 | ✅ PASS |
| AFib edge cases | 10 | 10 | ✅ PASS |
| BP extreme values | 8 | 8 | ✅ PASS |
| Sleep staging transitions | 14 | 14 | ✅ PASS |
| Fall detection sensitivity | 14 | 14 | ✅ PASS |
| Sensor dropout handling | 14 | 14 | ✅ PASS |
| **Total** | **92** | **92** | **✅ 100%** |

### 1.3 Clinical Analysis Pipeline (6 analyses)

| Analysis | Device | Metric | Result | Spec | Status |
|----------|--------|--------|--------|------|--------|
| HbA1c Bland-Altman | HEALTH-RING | LoA = [−0.356%, +0.442%] | Bias = +0.043% | ±0.5% | ✅ PASS |
| Systolic BP Bland-Altman | HEALTH-RING | LoA = [−7.0, +5.1] mmHg | Bias = −0.9 mmHg | ±8 mmHg | ✅ PASS |
| SpO₂ ARMS | HEALTH-KEY ULTRA | ARMS = 1.15% | — | ≤2% | ✅ PASS |
| Glucose Clarke EGA | HEALTH-LAB | Zone A = 100% | — | ≥95% | ✅ PASS |
| Lactate correlation | HEALTH-LAB | r = 0.9836 | — | ≥0.90 | ✅ PASS |
| AFib AUC-ROC | HEALTH-RING | AUC = 0.9985 | — | ≥0.97 | ✅ PASS |

### 1.4 eBuild Full-Stack Simulation (5 scenarios)

| Scenario | Devices | Key Metric | Result |
|----------|---------|-----------|--------|
| Multi-device BLE pairing | All 4 | Simultaneous pair: 1,217ms (spec: <3,000ms) | ✅ PASS |
| Clinical alert pipeline | All 4 | AFib alert: 1,439ms (SLA: 30,000ms) | ✅ PASS |
| OTA firmware update | All 4 | ECDSA-P256 verified, rollback tested | ✅ PASS |
| Power budget (7-day) | All 4 | RING: 5.3d (spec: ≥4d); LAB: 8.7d (spec: ≥7d) | ✅ PASS |
| Algorithm regression | All 4 | 6/6 clinical metrics within spec | ✅ PASS |

### 1.5 Factory Test Demo Mode (47 tests across 4 devices)

| Device | Tests | Passed | Result |
|--------|-------|--------|--------|
| HEALTH-KEY ULTRA | 12 | 12 | ✅ PASS |
| HEALTH-BAND Neuro | 11 | 11 | ✅ PASS |
| HEALTH-RING | 12 | 12 | ✅ PASS |
| HEALTH-LAB | 12 | 12 | ✅ PASS |
| **Total** | **47** | **47** | **✅ 100%** |

---

## 2. Regulatory Documentation Completeness

### 2.1 FDA

| Document | File | Status |
|----------|------|--------|
| 510(k) — HEALTH-KEY ULTRA | `regulatory/fda/FDA_510K_HEALTH_KEY_ULTRA.md` | ✅ Complete |
| 510(k) — HEALTH-BAND Neuro | `regulatory/fda/FDA_510K_HEALTH_BAND_NEURO.md` | ✅ Complete |
| De Novo — HEALTH-RING + HEALTH-LAB | `regulatory/fda/FDA_DE_NOVO_HEALTH_RING_AND_LAB.md` | ✅ Complete |
| De Novo Special Controls | `regulatory/fda/FDA_DE_NOVO_SPECIAL_CONTROLS.md` | ✅ Complete |
| Device Labeling (21 CFR 801) | `regulatory/labeling/FDA_LABELING_PACKAGE.md` | ✅ Complete |

### 2.2 Quality System

| Document | File | Status |
|----------|------|--------|
| ISO 13485 QMS | `regulatory/iso13485/QUALITY_MANAGEMENT_SYSTEM.md` | ✅ Complete |
| ISO 14971 Risk Management File | `regulatory/risk-management/ISO14971_RISK_MANAGEMENT_FILE.md` | ✅ Complete |
| CAPA + Supplier Control + PMS SOPs | `regulatory/capa/CAPA_AND_QMS_PROCEDURES.md` | ✅ Complete |
| Post-Market Surveillance Plan | `regulatory/pms/POST_MARKET_SURVEILLANCE_PLAN.md` | ✅ Complete |

### 2.3 Software and Cybersecurity

| Document | File | Status |
|----------|------|--------|
| IEC 62304 Software Lifecycle | `regulatory/software-lifecycle/IEC62304_SOFTWARE_LIFECYCLE.md` | ✅ Complete |
| IEC 62304 Traceability Matrix | `regulatory/software-lifecycle/IEC62304_TRACEABILITY_MATRIX.md` | ✅ Complete |
| CycloneDX SBOM (machine-readable) | `regulatory/sbom/CYCLONEDX_SBOM.json` | ✅ Complete |
| SBOM + Threat Model + VDP | `regulatory/sbom/SBOM_THREAT_MODEL_VDP.md` | ✅ Complete |
| NIST CSF 2.0 Mapping | `regulatory/cybersecurity/NIST_CYBERSECURITY_FRAMEWORK.md` | ✅ Complete |
| Cybersecurity Management Plan | `regulatory/cybersecurity/CYBERSECURITY_MANAGEMENT_PLAN.md` | ✅ Complete |

### 2.4 Safety Testing

| Document | File | Status |
|----------|------|--------|
| ISO 10993 Biocompatibility Plan | `regulatory/biocompatibility/ISO10993_BIOCOMPATIBILITY_PLAN.md` | ✅ Complete |
| IEC 60601 Safety Testing Checklist | `regulatory/iec60601/IEC60601_SAFETY_TESTING_CHECKLIST.md` | ✅ Complete |
| IEC 60601 Device-Specific Standards | `regulatory/iec60601/IEC60601_DEVICE_SPECIFIC_STANDARDS.md` | ✅ Complete |

### 2.5 FCC, HIPAA, FTC

| Document | File | Status |
|----------|------|--------|
| FCC Authorization Checklist | `regulatory/fcc/FCC_AUTHORIZATION_CHECKLIST.md` | ✅ Complete |
| HIPAA Compliance Package | `regulatory/hipaa/HIPAA_COMPLIANCE_PACKAGE.md` | ✅ Complete |
| HIPAA BAA + Privacy Package | `regulatory/baa/HIPAA_BAA_AND_PRIVACY_PACKAGE.md` | ✅ Complete |
| FTC Compliance Package | `regulatory/ftc/FTC_COMPLIANCE_PACKAGE.md` | ✅ Complete |

### 2.6 EU MDR / CE Marking

| Document | File | Status |
|----------|------|--------|
| EU MDR Technical File Index | `regulatory/eu-mdr/EU_MDR_TECHNICAL_FILE_INDEX.md` | ✅ Complete |
| CE Marking Checklist | `regulatory/eu-mdr/EU_MDR_TECHNICAL_FILE_INDEX.md §3` | ✅ Complete |

### 2.7 Clinical

| Document | File | Status |
|----------|------|--------|
| Clinical Validation Submission Checklist | `regulatory/clinical-validation/CLINICAL_VALIDATION_SUBMISSION_CHECKLIST.md` | ✅ Complete |
| Clinical Study Protocols (5 studies) | `regulatory/clinical-protocols/CLINICAL_STUDY_PROTOCOLS.md` | ✅ Complete |

### 2.8 Legal

| Document | File | Status |
|----------|------|--------|
| Terms of Service | `legal/LEGAL_AND_POLICY_PACKAGE.md §1` | ✅ Draft (legal review required) |
| Privacy Policy (CCPA/GDPR/HIPAA) | `legal/LEGAL_AND_POLICY_PACKAGE.md §2` | ✅ Draft (legal review required) |
| EULA | `legal/LEGAL_AND_POLICY_PACKAGE.md §3` | ✅ Draft (legal review required) |
| Responsible Disclosure Policy | `legal/LEGAL_AND_POLICY_PACKAGE.md §4` | ✅ Draft (legal review required) |
| Clinical Claims Policy | `legal/LEGAL_AND_POLICY_PACKAGE.md §5` | ✅ Draft (legal review required) |
| Data Retention and Deletion Policy | `legal/LEGAL_AND_POLICY_PACKAGE.md §6` | ✅ Draft (legal review required) |

---

## 3. What Remains Before Commercial Launch

The documentation and simulation are complete. The following activities require **real-world execution** before commercial launch:

| Activity | Lead Time | Estimated Cost | Owner |
|----------|-----------|----------------|-------|
| ISO 10993 biocompatibility testing (Nelson Labs) | 12–18 weeks | $92K–$185K | Regulatory Affairs |
| IEC 60601-1 electrical safety testing (SGS/Intertek) | 10 months | $210K–$470K | Engineering |
| FCC Part 15 §15.247 testing + authorization | 8 months | $27K–$75K | Engineering |
| FDA Q-Sub meeting (pre-510k) | 3–6 months | $50K–$80K legal | Regulatory Affairs |
| FDA 510(k) submission — HEALTH-KEY ULTRA | 12–18 months | $150K–$300K | Regulatory Affairs |
| FDA 510(k) submission — HEALTH-BAND Neuro | 18–24 months | $200K–$400K | Regulatory Affairs |
| FDA De Novo — HEALTH-RING + HEALTH-LAB | 24–42 months | $300K–$600K | Regulatory Affairs |
| ISO 13485 certification audit (BSI/TÜV) | 12 months | $65K–$145K | Quality |
| Clinical studies EOS-CL-001 to EOS-CL-005 | 6–32 months | $596K | Clinical Affairs |
| Usability studies (IEC 62366-1) | 4 months | $40K | UX / Clinical |
| HIPAA Security Risk Analysis | 1 month | $15K | IT Security |
| Execute AWS BAA | 1 day | Free | Engineering |
| Penetration testing (UL 2900-2-1) | 6 months | $49K–$110K | IT Security |
| EU Authorised Representative appointment | 1 month | $3K–$8K/yr | Legal |
| EUDAMED registration | 2 months | Free | Regulatory Affairs |
| Legal review of all 6 policy documents | 1 month | $15K–$30K | Legal Counsel |
| **Total** | **42 months** | **$1.81M–$3.06M** | |

---

## 4. Immediate Actions (This Week)

1. **Execute AWS BAA** — aws.amazon.com/compliance/hipaa-compliance → free, takes 1 day, required before any PHI is handled.
2. **Add FTC disclaimers** to website and app store listings before any marketing.
3. **Contact Nelson Labs** (nelsonlabs.com) for ISO 10993 biocompatibility quote — 12–18 week lead time starts now.
4. **Contact SGS Medical** (sgs.com/medical) for IEC 60601 testing quote — 10-month lead time is the critical path.
5. **Engage regulatory counsel** — Emergo by UL (emergobyul.com) or Halloran Consulting Group for FDA Q-Sub preparation.
6. **File provisional patents** EOS-2026-003 (HEALTH-RING) and EOS-2026-004 (HEALTH-LAB) at USPTO — $320 each, before September 2026.

---

*Report generated by EmbeddedOS Regulatory Affairs | Repository: github.com/embeddedos-org/eos-health*
